Healthcare ❯ Pharmaceuticals ❯ Clinical Trials

Cancer Treatments

Melanoma Pancreatic Ductal Adenocarcinoma

Regeneron Slides as Melanoma Combo Fails to Beat Keytruda in Phase 3

The miss triggered target cuts alongside a securities investigation into prior comments.

Moderna, Merck Melanoma Vaccine Shows Durable Five-Year Benefit as Stock Hits 52-Week High